Takashi Nishida Topcon, Code C (Consultant/Contractor);
Sasan Moghimi National Eye Institute, University of California Tobacco-Related Disease Research Program, Code F (Financial Support);
Evan Walker None;
Gopikasree Gunasegaran None;
Jo-Hsuan Wu None;
Alireza Kamalipour Fight for Sight, Code F (Financial Support);
Golnoush Mahmoudinezhad None;
Linda Zangwill Abbvie, Topcon, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec, Optovue, Heidelberg Engineering, and Topcon, Code F (Financial Support), Carl Zeiss Meditec, Code P (Patent);
Robert Weinreb Abbvie, Aerie Pharmaceuticals, Allergan, Amydis, Equinox, Eyenovia, Iantrek, IOPtic, Implandata, Nicox, and Topcon, Code C (Consultant/Contractor), National Eye Institute, Heidelberg Engineering, Carl Zeiss Meditec, Konan Medical, Optovue, Zilia, Centervue, and Topcon, Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent)